Sort
17,288 grants matching “multiple sclerosis”
Mechanisms for matrix-dependent BBB dysfunction
$182,650Richard Scott Beard · Boise State University · P20 · FY2019 · GM
TR&D 2: Quantitative multi-contrast MRI at 3T and 7T.
$182,592Peter Cm Van Zijl · Hugo W. Moser Res Inst Kennedy Krieger · P41 · FY2018 · EB
TR&D 2: Quantitative multi-contrast MRI at 3T and 7T.
$182,592Peter Cm Van Zijl · Hugo W. Moser Res Inst Kennedy Krieger · P41 · FY2016 · EB
TR&D 2: Quantitative multi-contrast MRI at 3T and 7T.
$182,592Peter Cm Van Zijl · Hugo W. Moser Res Inst Kennedy Krieger · P41 · FY2020 · EB
TR&D 2: Quantitative multi-contrast MRI at 3T and 7T.
$182,592Peter Cm Van Zijl · Hugo W. Moser Res Inst Kennedy Krieger · P41 · FY2017 · EB
TR&D 2: Quantitative multi-contrast MRI at 3T and 7T.
$182,592Peter Cm Van Zijl · Hugo W. Moser Res Inst Kennedy Krieger · P41 · FY2019 · EB
The effect of vitamin D3 on markers of oxidative stress in boys with X-linked ALD
$182,563Keith Van Haren · Stanford University · K23 · FY2019 · NS
MYELIN PO GLYCOPROTEIN: STRUCTURE &ADHESIVE MECHANISMS
$182,562Boston College · R01 · FY2001 · NS
mTOR-containing Protein Complexes in the Pathogenesis of Tuberous Sclerosis
$182,556Arnold Kristof · Mcgill University · R01 · FY2009 · CA
Analytical & Histopathology Core
$182,555Joseph Peter Grande · Mayo Clinic Rochester · P01 · FY2008 · HL
DISSECTING THE IMMUNE BASIS OF DISEASE AND THERAPY
$182,524Nitin J Karandikar · Ut Southwestern Medical Center · K24 · FY2009 · AI
DISSECTING THE IMMUNE BASIS OF DISEASE AND THERAPY
$182,524Nitin J Karandikar · Ut Southwestern Medical Center · K24 · FY2011 · AI
Dissecting the Immune Basis of Disease and Therapy
$182,524Nitin J Karandikar · University Of Iowa · K24 · FY2013 · AI
DISSECTING THE IMMUNE BASIS OF DISEASE AND THERAPY
$182,524Nitin J Karandikar · Ut Southwestern Medical Center · K24 · FY2012 · AI
DISSECTING THE IMMUNE BASIS OF DISEASE AND THERAPY
$182,524Nitin J Karandikar · Ut Southwestern Medical Center · K24 · FY2010 · AI
Infection in Multiple Sclerosis (MS)
$182,501Edward L. Hogan · Augusta University · R21 · FY2006 · NS
Establishment of inducible astrocyte specific p38 MAPK knockout mouse line
$182,500Shaohua Yang · University Of North Texas Hlth Sci Ctr · R21 · FY2014 · NS
Leveraging genetics and environment to predict presymptomatic multiple sclerosis
$182,468Zongqi Xia · University Of Pittsburgh At Pittsburgh · K08 · FY2016 · NS
Assessing MRI Biomarkers of White Matter Injury
$182,446Sheng-Kwei Song · Washington University · P01 · FY2012 · NS
microRNA target site RNA-directed oligonucleotide topical therapeutics in psoriasis
$182,408Jeffrey R. Bender · Yale University · R21 · FY2022 · AR
Immunotherapy of prostate cancer using an anti-CD6 monoclonal antibody
$182,325David Alan Fox · University Of Michigan At Ann Arbor · R21 · FY2024 · CA
PDGF-A AND FGF2: IN VIVO ROLES DURING CNS REMYELINATION
$182,311Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2001 · NS
ULTRASOUND-INDUCED DRUG DELIVERY THROUGH THE BLOOD-BRAIN BARRIER
$182,280Elisa E Konofagou · Columbia Univ New York Morningside · R21 · FY2008 · EY
Exploring novel disease mechanisms in RA linked to HLA class II risk
$182,270Jane Hoyt Buckner · Benaroya Research Inst At Virginia Mason · R21 · FY2019 · AR
Exploring the Effects of Rehabilitation on Brain Remodeling in Progressive MS
$182,167Victor William Mark · University Of Alabama At Birmingham · R21 · FY2010 · HD